Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.56 |
| ▸ | BAX | Q07812 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.52 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | IDH1 | O75874 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22129853 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL435149 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL9212518 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL122719 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL3893562 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL11576945 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| Diphenylether SCHEMBL9061108 | 0.82 | LTA4H (1.00) | LTA4HTSHRNR1H2BAXMAOA | |
| Diphenylether SCHEMBL2461810 | 0.82 | LTA4H (1.00) | LTA4HTSHRNR1H2BAXMAOA | |
| Diphenylether SCHEMBL4950525 | 0.82 | LTA4H (1.00) | LTA4HTSHRNR1H2BAXMAOA | |
| Diphenylether SCHEMBL12286 | 0.82 | LTA4H (1.00) | LTA4HTSHRNR1H2BAXMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108752412-B | Boswellic acid derivatives and their use | 沈阳药科大学 | 2020-10-13 | — | — | CN | claimed |
| US-10745372-B2 | Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and purification method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-08-18 | — | — | US | claimed |
| CN-105085386-A | Medical application of 2-(4-phenoxyphenoxy)fatty acyl pyridylamine | UNIV HUNAN | 2015-11-25 | — | — | CN | claimed |
| US-8710038-B2 | Pyrazole kinase modulators and methods of use | EXELIXIS, INC. (US) | 2014-04-29 | — | — | US | claimed |
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY | 2007-10-11 | — | — | US | claimed |
| EP-0289919-B1 | N-SUBSTITUTED AZOLES | BASF Aktiengesellschaft (DE) | 1993-03-17 | — | — | EP | claimed |
| EP-0412391-A1 | Cyclopropane thiocarboxylic acid amides | BASF Aktiengesellschaft (DE) | 1991-02-13 | — | — | EP | claimed |
| EP-0049397-A1 | A herbicidal composition | AMERICAN HOECHST CORPORATION (US) | 1982-04-14 | — | — | EP | claimed |
| US-4301295-A | ANTILIPEMIC AND ANTICHOLESTEROL AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-11-17 | — | — | US | claimed |
| CN-118206421-A | Dihydro fulvene derivative and preparation method thereof | 河南省科学院化学研究所有限公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-4327139-A1 | METHOD FOR MANUFACTURING AN OPTICAL MATERIAL AND COMPOSITION USED IN THIS METHOD | Mitsui Chemicals, Inc. (JP) | 2024-02-28 | — | — | EP | disclosed |
| CN-116940867-A | Method for manufacturing optical material and composition used in the method | 三井化学株式会社 | 2023-10-24 | — | — | CN | disclosed |
| WO-2023190286-A1 | PEST CONTROLLING AGENT | 日本化薬株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2022259985-A1 | PEST CONTROLLING AGENT | 日本化薬株式会社 | 2022-12-15 | — | — | WO | disclosed |
| EP-0049436-A1 | Process for producing highly stereoregular alpha-olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-04-14 | — | — | EP | disclosed |
| US-4316993-A | Process for the preparation of 4-phenoxy-phenols | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-02-23 | — | — | US | disclosed |
| EP-0001267-B1 | MASS COLORATION OF LINEAR POLYESTERS | CIBA-GEIGY AG (CH) | 1981-09-16 | — | — | EP | disclosed |
| US-4231918-A | THIOINDIGO OR DIOXAZINE PIGMENT AND DYE | CIBA-GEIGY CORPORATION (US) | 1980-11-04 | — | — | US | disclosed |
| EP-0001267-A1 | Mass coloration of linear polyesters | CIBA-GEIGY AG (CH) | 1979-04-04 | — | — | EP | disclosed |
| US-3996191-A | DIOXAZINE DYES | CIBA-GEIGY AG (CH) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | GLP1R, GIPR, IAPP | LTA4H 1569/4885TSHR 100/4885NR1H2 1202/4885 |
| US-10745372-B2 | Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and purification method | ASH2L, MLLT1, FRG1 | LTA4H 1050/4885TSHR 3984/4885NR1H2 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.